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Abstract Primitive malignant renal tumours comprise 6%
of all childhood cancers. Wilms tumour (WT) or
nephroblastoma is the most frequent type accounting for
more than 90%. Imaging alone cannot differentiate
between these tumours with certainty but it plays an
important role in screening, diagnostic workup, assess-
ment of therapy response, preoperative evaluation and
follow-up. The outcome of WT after therapy is excellent
with an overall survival around 90%. In tumours such as
those where the outcome is extremely good, focus can be
shifted to a risk-based stratification to maintain excellent
outcome in children with low risk tumours while
improving quality of life and decreasing toxicity and
costs. This review will discuss the imaging issues for
WT from the European perspective and briefly discuss
the characteristics of other malignant renal tumours
occurring in children and new imaging techniques with
potential in this matter.
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Introduction
Primitive malignant renal tumours comprise 6% of all
childhood cancers. Wilms tumour (WT) or nephroblastoma
is the most frequent type accounting for more than 90% [1].
All other malignant renal tumours occurring in children
such as clear cell sarcoma, rhabdoid tumour and renal cell
carcinoma are rare.
Imaging alone cannot differentiate between these tumours
with certainty but it plays an important role in screening,
diagnostic workup, assessment of therapy response, preop-
erative evaluation andfollow-up. Abdominal US with colour
Doppler, chest radiograph, CTand MRI are commonly used
for anatomical staging and detection of metastases. New
techniques such as 18F-fluorodeoxyglucose positron emis-
sion tomography (FDG-PET) CT and diffusion-weighted
imaging (DWI) with MRI are being evaluated for their
potential value in the imaging strategy of malignant renal
tumours in adults and children.
The outcome of WT after therapy is excellent with an
overall survival around 90% [1]. In tumours such as those
where the outcome is extremely good, focus can be shifted
to a risk-based stratification to maintain excellent outcome
in children with low risk tumours while improving quality
of life and decreasing toxicity and costs. At the same time it
is important to identify the small group of children with
high risk tumours who might benefit from intensified
therapy. In this strategy, care should be taken not to
increase the burden of invasive or ionizing diagnostic
investigations in all children [2].
The therapeutic approach for WT in Europe is different
from that in the United States [3, 4]. This review will
discuss the imaging issues for WT from the European
perspective and briefly discuss the characteristics of other
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Wilms tumour
Differential diagnosis
In Europe, WT is treated according to the Société
Internationale d’Oncologie Pédiatrique (SIOP) 2001 trial
and study protocol [5]. Since biopsy is not required in this
protocol, renal tumours with features matching WT are
treated accordingly. The diagnosis will be confirmed on
pathological examination after preoperative chemotherapy
and surgery. The advantages of preoperative chemotherapy
have been extensively published in various papers. Anal-
ysis of the SIOP-9 study showed that in only 2% of
children preoperative chemotherapy was given inappropri-
ately for benign lesions and in 3% for other malignant
lesions [6]. This seems acceptable since preoperative
chemotherapy of short duration (4 weeks) with vincristine
and actinomycin-D is not associated with long-term
complications and is also effective in most non-Wilms
tumours. Vujanic et al. [7] reported the results of pre-
treatment needle biopsies in children with non-metastatic
renal tumours. In 84% the diagnosis of WT was confirmed
and in 12% it revealed either an alternative renal malig-
nancy or neuroblastoma. In 4% the specimen was not
diagnostic and in 2% significant complications were
described. Whether the pathological information provided
by biopsy before therapy is worth the possible complica-
tions is not yet proved.
Sometimes a neuroblastoma invading the kidney can
mimic a WT. The presence of calcifications and the typical
encasement of vessels are signs in favour of neuroblastoma.
Elevation of catecholamine levels in 24 h urine studies will
confirm the diagnosis in more than 90% [8]. Meta-
iodobenzylguanidine (MIBG)-Iodine
123 radiotargeting can
be very helpful in this situation (Fig. 1).
Imaging at diagnosis
The initial treatment consists of chemotherapy. This will
reduce tumour size, hence facilitating subsequent surgery and
lowering the risk of intra-operative tumour rupture. Pre-
operative chemotherapy will also downstage tumours and
reduce postoperative therapy. Clinical history, physical exam-
inationanddiagnosticimagingwill assistindifferentiatingWT
fromother renal pathology, either benign ormalignant. Needle
biopsy is recommended in cases of unusual clinical presenta-
tion (age above 6 years, urinary infection, septicaemia, psoas
inflammation) or unusual imaging findings for WT (calcifica-
tion, voluminous lymph nodes, renal parenchyma not visible,
almost entirely extrarenal mass).
Furthermore, imaging will depict the locoregional
extension, metastatic spread and contralateral disease.
Initial imaging should consist of abdominal US with
colour Doppler and chest radiograph in 2 projections; frontal
Fig. 1 Axial T2-W fat-supressed
MR. 11-month-old boy with a
right abdominal mass with a
partially intrarenal localization
(black arrow) and liver
metastases. 123-Iodine-MIBG-
scan was positive for
neuroblastoma
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tumour and the expertise of the radiologist, complementary
abdominal contrast-enhanced CT or MRI will be required to
further delineate tumour extension and exclude bilateral
disease with certainty (Fig. 2). Although CT is more readily
available and faster, MRI is the preferred technique since it
does not use ionizing radiation, even though general
anaesthesia or sedation is usually necessary in these young
children. If there are suspicious pulmonary lesions on chest
radiograph, additional chest CT is recommended.
The primary tumour
WT presents as a large spherical mass, with a mainly
intrarenal localization. The tumour can be solid and
homogeneous but is usually heterogeneous with areas of
haemorrhage, necrosis or cysts. In <15% the tumour
contains calcifications. The remaining normal kidney tissue
can be difficult to detect but is often stretched at the
periphery of the tumour (Fig. 3). US is an excellent
technique to assess the movement of the mass in relation
to its surroundings in order to exclude invasion or
adherence to adjacent organs. Measurement of the tumour
in three planes is required. If the tumour is large and
difficult to delineate from the kidney, kidney and tumour is
measured as one. On CT and MRI the tumour enhances less
than normal renal tissue making it more conspicuous.
The contralateral kidney
Whenever a renal tumour (presumably a WT) is detected, the
contralateral kidney should be examined for synchronous
bilateral disease that occurs in 5% of children. Bilateral
disease comprises bilateral WT or bilateral nephrogenic rests
(NRs) (nephroblastomatosis) and/or WT. Other lesions may
mimic bilateral disease, including lymphoma, leukaemia or
polycystic kidney disease (Fig. 4). Bilateral disease upstages
the patient to stage V [5]. The aim of treatment then becomes
to cure and at the same time preserve as much functional
renal tissue as possible by using parenchyma-sparing
surgery. Preoperative imaging will then play a crucial role
in determining the possibilities of partial nephrectomy.
In case of detection of other non-malignant abnormali-
ties of the other kidney endangering the renal function (e.g.
dysplasia, hydronephrosis) or absence of the other kidney,
partial nephrectomy must also be considered.
Bilateral disease occurs more frequently in children with
NRs in their kidneys. NRs are clusters of embryonal
nephroblastic cells that can persist into childhood and have
Fig. 3 2.5-year-old girl with a left renal mass. US shows the kidney
stretched around the tumour
Fig. 4 Twelve-year-old girl with Burkitt lymphoma. Coronal T2-W
MR shows in addition to a large abdominal mass (partially shown,
white arrows), multiple nodular lesions in both kidneys
Fig. 2 Axial T2-W fat-suppressed MR shows a large tumour with left
renal origin. The mass was too large to be adequately imaged with US
alone
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detection of these often small lesions important. Rohrsch-
neider et al. [10] compared the sensitivity of US, CT and
MRI to detect macroscopic NRs and concluded that US is
less sensitive than CT and MRI. The value of high-
resolution US techniques such as tissue harmonic imaging
has not yet been evaluated. Nowadays, surgeons no longer
explore the contralateral kidney before nephrectomy since
imaging is sufficiently capable of detecting small lesions in
the contralateral kidney [11, 12]. Differentiating benign
NRs from WT is important for it will obviously determine
the appropriate management. MRI shows distinctly differ-
ent characteristics on pre-contrast T2-weighted images
between sclerotic and hyperplastic NRs and WT. This
might help in decision making about continuation of
chemotherapy or partial nephrectomy [13]. This is partic-
ularly useful since pathological examination of a small
biopsy specimen cannot discriminate with confidence
between benign NRs and WT (Fig. 5).
The managementofbilateral disease isstill one ofthe most
challenging issues in WT especially when nephron-sparing
surgery is not possible due to the location of the lesions.
The rest of the abdomen
Enlarged lymph nodes are frequently encountered in the
region of the tumour. Imaging studies are unable to
differentiate between reactive nodes or tumour positive
nodes. Hence lymph node biopsies will be performed
during surgery, according to the protocol.
WT can metastasise to the liver in 15–20% of children
making meticulous inspection of the hepatic parenchyma
necessary.
Although rare, tumour rupture is a major risk factor for
abdominal relapse. The reason for preoperative chemother-
apy in the SIOP protocol is to decrease the risk of
intraoperative tumour rupture, that would upstage the
patient to stage III (Table 1). These children will then
receive abdominal radiotherapy as part of their postopera-
Fig. 5 Two-year-old girl with
bilateral nephroblastomatosis.
a. Coronal T1-W MR after
gadolinium administration
shows multiple bilateral round
lesions with different patterns of
enhancement. b. Axial T2-W
MR. The lesions show variable
signal intensity. Some of the
lesions eventually developed
into WT
Table 1 Current SIOP criteria for staging of WT [5]
Stage I
The tumour is limited to the kidney or surrounded by a fibrous
pseudocapsule if outside of the normal contours of the kidney. The
renal capsule or pseudocapsule may be infiltrated but the tumour
does not reach the outer surface and it is completely resected
The tumour may be protruding into the pelvic system and dipping
into the ureter but it is not infiltrating their walls
The vessels of the renal sinus are not involved
Intrarenal vessel involvement may be present
Necrotic tumour or chemotherapy-induced changes in the perirenal
fat or the renal sinus do not upstage if completely excised
Stage II
The tumour extends beyond the kidney or penetrates through the
renal capsule and/or fibrous capsule into perirenal fat but is
completely resected
Tumour infiltrates the renal sinus and/or invades blood and
lymphatic vessels outside the renal parenchyma but is completely
resected
Tumour infiltrates adjacent organs or vena cava but is completely
resected
Stage III
a. Incomplete excision of the tumour which extends beyond resection
margins (gross or microscopic tumour remains postoperatively)
b. Any abdominal lymph nodes are involved
c. Tumour rupture before or during surgery (irrespective of other
criteria for staging)
d. The tumour has penetrated through the peritoneal surface
e. Tumour implants are found on the peritoneal surface
f. Tumour thrombi present at the resection margins of vessels or
ureter, transsected or removed piecemeal by the surgeon
g. The tumour has been surgically biopsied (wedge biopsy) prior to
preoperative chemotherapy or surgery
The presence of necrotic tumour or chemotherapy-induced changes in
a lymph node or at the resection margins is also assigned stage III
Stage IV
Haematogenous metastases (lung, liver, bone, brain, etc.) or lymph
node metastases outside the abdomino-pelvic region
Stage V
Bilateral renal involvement at diagnosis. Each side should be
substaged according to the above classifications
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histology. In the SIOP protocol, the local stage is
determined by pathological examination of the nephrecto-
my specimen. However, clinical signs and imaging could
also suggest rupture. In the current protocol these findings
are not taken into account for the final local staging. Brisse
et al. [14] demonstrated from a retrospective study of 57
patients with either clinical and/or CT signs of rupture that
detailed analysis of abdominal CT scans may distinguish
intraperitoneal from retroperitoneal ruptures. These imaging
findings are not always coupled with clinical signs. They
suggested that diagnostic features of intraperitoneal rupture
should be considered as stage III regardless of other
postoperative pathological criteria. On the other hand, they
found no increased risk for abdominal relapse in children
with isolated retroperitoneal rupture who did not receive
abdominal radiotherapy. These findings encourage the
possible need to value imaging findings of both retroper-
itoneal and intraperitoneal rupture when considering post-
operative treatment, to prevent respectively over- and under
treatment of these children.
Small amounts of non-haemorrhagic peritoneal fluid
should not be considered as a sign of rupture: it can
correspond to a peritoneal inflammatory reaction to rapid
tumour growth or be due to inferior vena cava (IVC)
compression or thrombosis [3].
In 4–10% of children the tumour extends into the IVC
[15]. Preoperative chemotherapy will usually at least
decrease the size of the tumour thrombus and possibly
even induce resolution of the IVC extension. This will
reduce the risks of massive haemorrhage or pulmonary
embolus during surgery. US in combination with colour
Doppler studies is the most reliable modality to examine the
patency of the IVC (Fig. 6)[ 16].
The lungs
Lung metastases are present in 15–20% of children with
WT. In the current SIOP protocol chest radiograph (CXR)
(AP or PA and lateral view) is still the basic imaging tool to
exclude pulmonary metastases. Complementary chest CT is
recommended only in cases of distinct or suspicious lesions
on CXR [5]. In North America, CT has become the routine
method of diagnosis for assessment of pulmonary lesions
since it is widely accepted that chest CT is a more sensitive
technique for detecting pulmonary nodules than conven-
tional radiographs. However, CT cannot differentiate
between small benign pulmonary lesions (that frequently
occur in children) and metastases [17–19]. Moreover, it has
not been proven that detecting smaller lesions at diagnosis
(and possibly also benign lesions) will improve the
outcome of WT patients [18, 20–22]. The ongoing
discussion around the dilemma between using the most
accurate imaging technique to detect pulmonary lesions and
avoiding overtreatment in children with a very good overall
prognosis has been recently summarized by Owens et al. [3,
23, 24]. In the current SIOP protocol a special clause is
made for patients with lung lesions detected on chest CT
and not on CXR. These lesions are called CT-only lung
metastases. The SIOP protocol proscribes that these lesions
should be ignored and the patients with CT-only nodules
should be treated as if without lung metastases (double
agent instead of three-drug chemotherapy and no lung
irradiation). One of the aims of the study is to evaluate the
outcome of these patients with CT-only metastases. If it is
not different from patients without CT-only lesions, with
same stage and histology, it could make detection of these
lesions unnecessary and hence chest CT redundant at
diagnosis. It will also prevent these patients from receiving
Fig. 6 Five-year-old girl with
left sided WT. Abdominal US
shows a large tumour thrombus
in the IVC (white arrows)
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the other hand, patients with CT-only metastases do worse,
chest CT should undoubtedly become the mandatory
diagnostic tool in the imaging strategy of WT.
Preoperative imaging
Most tumours decrease in size during preoperative chemo-
therapy and/or show changes in appearance indicating
necrosis. The tumour rarely increases in size (5%),
predicting poorer event-free and overall survival [25]. The
surgeon needs to know the extent of the tumour, its location
within the kidney and its relation to the central vessels,
diaphragm, liver, spleen, pancreas and adrenal glands
before operation. Enlarged lymph nodes, intra-abdominal
metastases (mainly liver) and thrombus in renal vein, IVC
or right atrium must be looked for. US is often sufficient to
answer these questions and in difficult cases it is recom-
mended to perform the examination in the presence of the
surgeon. If US does not provide satisfactory information,
MRI is the preferred complementary modality because of
the lack of ionizing radiation.
Kidney-sparing surgery is indicated in cases of bilateral
disease, underlying urologic or nephrologic disease (e.g.
horseshoe kidney, single kidney) or genetic syndromes with
an increased risk of WT. In this context multiplanar
acquisitions with MRI are extremely helpful in depicting
the surgical possibilities and margins. Partial nephrectomy
can also be considered in cases of simple unilateral disease;
the SIOP protocol mentions contraindications for this
procedure [26]. Some of these can be detected by the
radiologist: tumour infiltrating into extrarenal structures,
intra-abdominal metastases or enlarged lymph nodes,
thrombus in the renal vein or IVC, tumour involving more
than 1/3 of the kidney, multifocal tumour, central location
and involvement of calyces.
Intraoperative US may also assist in defining the tumour
margins more accurately.
Follow-up
Tumour relapse in WT is infrequent and typically occurs in
the first 2 years after therapy. Considering the overall good
prognosis of WT, imaging after treatment should also be
minimally invasive and minimally harmful. Since recur-
rence of WT can be cured, it is important to detect it
(Fig. 7). Children are followed with CXR and abdominal
US. Abdominal US is recommended at a higher frequency
in cases of metastatic disease in complete remission, if
nephrogenic rests are present, in cases of bilateral disease
and after partial nephrectomy, than for children with non-
metastatic disease at diagnosis. There is no evidence or
consensus about the frequency of follow-up studies.
Screening
Most WT occur in otherwise healthy children. A small
number occur in children with genetic syndromes. Scott et
al. [27] have produced guidelines for WT surveillance
based on a review of current practice and available
evidence. In summary, they recommend using renal US
every 3–4 months until 5 or 7 years of age to screen
children with a risk of developing WT >5%, depending on
the syndrome. These children should first be offered a
review by a clinical geneticist and detected lesions should
be managed at a specialist centre.
Other renal malignancies of childhood
Clear cell sarcoma
Clear cell sarcoma of the kidney (CCSK) occurs in children
with a peak age of incidence similar to that of WT. They
account for approximately 4% of childhood renal tumours.
Metastatic spread is wider than in WT; to bone, brain, liver,
lymph nodes and lungs, in some cases long after nephrec-
tomy. Radioisotope bone scan (99 m-Technetium-methy-
lene diphosphate), MRI of the brain and chest CT are
recommended for staging. Children with CCSK are at risk
for relapse for a longer period of time than WT and they
have a poorer outcome with long-term survival rates of 60–
70% [1]. Imaging studies cannot distinguish between
CCSK and WT (Fig. 8)[ 1, 28].
Rhabdoid tumours of the kidney
Rhabdoid tumours of the kidney (RTK) account for 1–2%
of renal malignancies in childhood. RTK is a highly
Fig. 7 Nine-year-old girl with recurrence detected on routine US. She
had been in complete remission over a 7 year period after a stage 2
intermediate risk WT. Courtesy of Dr. S. Robben
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mainly in infants. Brain metastases or synchronous primary
intracranial masses are often present at diagnosis. The brain
lesion is usually near the midline and often in the posterior
fossa. Survival is often <1 year from diagnosis. Imaging
studies demonstrate a large, centrally located, heteroge-
neous soft-tissue mass involving the renal hilum. The
appearance may closely resemble WT but subcapsular fluid
collections, tumour lobules separated by areas of necrosis
or haemorrhage and linear calcifications outlining tumour
lobules can suggest the diagnosis of RTK. Renal vein
invasion is common. RTK can metastasise to lungs, liver
and brain [28, 29].
Renal cell carcinoma
Renal cell carcinoma (RCC) is the most common renal
tumour in adults. It presents very rarely in childhood (1%).
Children with tuberous sclerosis or von Hippel-Lindau
disease or prior chemotherapy for cancer are at risk [30].
There also seems to be a higher incidence in children who
have been previously treated for neuroblastoma [31].
Compared to WT, RCC more often presents bilaterally
and is more likely to metastasize to bone. Calcifications are
more frequently seen than in WT [28].
In contrast to adults, locoregional nodal spread seems
not to worsen the prognosis [32].
Renal medullary carcinoma
Renal medullary carcinoma is a highly malignant tumour of
epithelial origin occurring almost exclusively in adolescents
and young adults with sickle cell trait or sickle cell disease,
but not homozygous sickle cell disease [33, 34]. The age
range at presentation is 10–39 years (mean age 20).
Imaging shows a centrally located infiltrative lesion
invading the renal sinus. The tumour is heterogeneous and
hypovascular. Intratumoural and subcapsular haemorrhage
are common. Calcifications have not been described. Renal
vein thrombosis or encasement is a common feature [35].
The tumour metastasises to lungs and liver and responds
poorly to chemotherapy or radiation therapy with a mean
survival of 15 weeks from diagnosis.
Congenital mesoblastic nephroma
Congenital mesoblastic nephroma (CMN) is the most
common solid tumour in the newborn. Below the age of
3 months, 72% of renal tumours are CMN. At 6 months this
percentage decreases to 16% [36]. Although it used to be
considered a congenital WT, it is now known to be a
distinct entity. It is usually detected within the first 3 months
or at least first year of life. Some cases are identified
prenatally. Imaging studies demonstrate a large solid intra-
renal mass that typically involves the renal sinus. It may
contain cystic, haemorrhagic and necrotic components.
Local infiltration of the perirenal tissues is common.
Nephrectomy alone with a wide surgical margin is usually
sufficient for cure. Local recurrence and spread to lungs,
brain or bones is rare [28].
Primitive neuroectodermal tumour
Primitive neuroectodermal tumour (PNET) of the kidney is
an extremely rare malignant tumour often presenting in an
advanced stage. Renal PNET behaves more aggressively
than PNET at other sites. It has poor response to
chemotherapy. Imaging studies show an infiltrative mass
that may present with calcifications and areas of necrosis.
The tumour can extend in the renal vein or IVC [37, 38].
New imaging techniques
FDG-PET
FDG-PET has been established for a number of diseases in
adults. In combination with CT the increased metabolic
activity can be anatomically localized and hence provides
more accurate information for staging; differentiating
benign from malignant disease and monitoring response to
treatment.
The applications in children are being further explored
and are promising in many areas. Although PET-scanning is
noninvasive, it does involve exposure to ionizing radiation
and the total dose is significant, usually around 10 mSv.
Uptake of FDG by WT has been described but a definitive
Fig. 8 Two-year-old girl with a clear cell sarcoma in the left kidney.
Contrast-enhanced abdominal CT shows the mass indistinguishable
from a WT on imaging studies
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metastases from benign pulmonary lesions PET-CT fails
since both conditions may involve increased glucose
metabolism. Furthermore, the current resolution of PET-
CT does not allow detection of micrometastases [39].
In a study by Misch et al. [40] 12 children with WTwere
examined with FDG-PET. Their results suggest that the
usefulness of this technique could lie not in initial staging
but in post-therapeutic imaging, non-invasive tumour
characterisation and restaging in cases of recurrent disease.
Normal excretion of FDG through the kidney can be a
limiting factor in detection of small renal tumours.
Quantitative MRI
DWI has been widely accepted as a powerful imaging
technique in neuroradiology. With advances in MRI
technology, diffusion-weighted sequences can now also be
used in body imaging with a minimal increase in imaging
time. For renal tumours in adults it is not yet possible to
confidently distinguish between benign and malignant renal
disease on the basis of quantitative assessment of ADC
measurements alone because of considerable overlap
between ADC values of benign and malignant disease
[41, 42]. However, DWI can help differentiate between
viable and necrotic areas within tumours that can be very
useful in selecting optimal biopsy sites and detecting viable
tumour after treatment [41]. Abdominal DWI is feasible in
children as well. Humphries et al. [43] examined three
children with nephroblastoma with DW techniques on
clinical 1.5-T MR units. They confirm that DWI in children
can help in guiding biopsy away from necrotic areas and
suggesting poor response to chemotherapy before tumour
shrinkage is expected. However, DWI was unable to
differentiate between benign and malignant lesions based
on ADC values alone [43].
Conclusion
For WT, a renal malignancy with an excellent prognosis,
the imaging guidelines for the European therapeutic
approach are outlined in the SIOP 2001 protocol. Soon
this trial will be closed and the results will be evaluated. In
the meantime a multidisciplinary team of physicians
involved in the management of children with WT is
encouraged to reflect on strategies for a new protocol in
order to answer remaining questions and assist in a new
risk-based approach. There is unquestionably a distinct task
for radiologists who are involved in national and interna-
tional paediatric oncology study groups. They will have to
face several challenges including selecting the most
accurate techniques (preferably non-ionizing and noninva-
sive) and choosing the right timing to perform them so that
the minority of children who might benefit from different or
more intensive therapy can be established reliably and
cost-effectively.
Hopefully, the results of the SIOP 2001 trial will bring
some clarity about the value of chest CT in the detection of
pulmonary metastases. The future will tell if quantitative
MRI techniques and/or FDG-PET will appear helpful in
discriminating renal lesions and facilitate the management
of bilateral disease.
For other less common childhood malignant renal
tumours such as clear cell sarcoma, for which a structured
diagnostic work-up is lacking, there is a need for evidence-
based strategies for staging and follow-up.
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